Vaccine-induced immunity by typical Mycobacterium tuberculosis Beijing strains

Emerging Infectious Diseases

Volumn 15, Issue 2, 2009, Pages 335-339

  Kremer, Kristin ^a   Van Der Werf, Marieke J ^b   Au, Betty K Y ^a   Anh, Dang D ^c   Kam, Kai M ^d   Van Doorn, H Rogier ^e   Borgdorff, Martien W ^b,e   Van Soolingen, Dick ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^c NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^d Hong Kong Special Administrative Region ^*  (China)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; STREPTOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BCG VACCINATION; CHINA; CLADISTICS; DISEASE COURSE; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; TUBERCULOSIS; VIET NAM;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENIC VARIATION; ANTITUBERCULAR AGENTS; BCG VACCINE; CHINA; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HONG KONG; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; TUBERCULOSIS; VACCINATION; VIETNAM;

EID: 63849295730     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1502.080795     Document Type: Article

References (16)

1. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis. 2006;12:736-43.
2. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, Ritacco V, et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol. 2003;133:30-7. DOI: 10.1046/j.1365-2249.2003.02171.x
3. Tsenova L, Harbacheuski R, Sung N, Ellison E, Fallows D, Kaplan G. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine. 2007;25:5126-32. DOI: 10.1016/j.vaccine.2006.11.024
4. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F, et al. Predominance of a single genotype of Mycobac- terium tuberculosis in countries of East Asia. J Clin Microbiol. 1995;33:3234-8.
5. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, Kremer K, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis. 2000;6:302-5.
6. Kremer K, Glynn JR, Lillebaek T, Niemann S, Kurepina NE, Kreiswirth BN, et al. Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol. 2004;42:4040-9. DOI: 10.1128/JCM.42.9.4040-4049.2004
7. Kurepina NE, Sreevatsan S, Plikaytis BB, Bifani PJ, Connell ND, Donnelly RJ, et al. Characterization of the phylogenic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA- dnaN region. Tuber Lung Dis. 1998;79:31-42. DOI: 10.1054/ tuld.1998.0003
8. Mokrousov I, Narvskaya O, Otten T, Vyazovaya A, Limeschenko E, Steklova L, et al. Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia. Res Microbiol. 2002;153:629-37. DOI: 10.1016/S0923-2508(02)01374-8
9. Mokrousov I, Jiao WW, Sun GZ, Liu JW, Valcheva V, Li M, et al. Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype. Antimicrob Agents Chemother. 2006;50:2820-3. DOI: 10.1128/AAC.00324-06
10. Rad ME, Bifani P, Martin C, Kremer K, Samper S, Rauzier J, et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis. 2003;9:838-45.
11. Hanekom M, van der Spuy GD, Streicher E, Ndabambi SL, McE- voy CR, Kidd M, et al. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol. 2007;45:1483-90. DOI: 10.1128/JCM.02191-06
12. Iwamoto T, Yoshida S, Suzuki K, Wada T. Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance. Antimicrob Agents Chemother. 2008;52:3805-9. DOI: 10.1128/AAC.00579-08
13. Borgdorff MW, de Haas P, Kremer K, van Soolingen D. Mycobacterium tubercuiosis Beijing genotype, the Netherlands. Emerg Infect Dis. 2003;9:1310-3.
14. Chan MY, Borgdorff MW, Yip CW, de Haas PEW, Wong WS, Kam KM, et al. Seventy percent of the Mycobacterium tuberculosis isolates in Hong Kong represent the Beijing genotype. Epidemiol Infect. 2001;127:169-71. DOI: 10.1017/S0950268801005659
15. Plikaytis BB, Marden JL, Crawford JT, Woodley CL, Butler WR, Shinnick TM. Multiplex PCR assay specific for the multidrug-re- sistant strain W of Mycobacterium tuberculosis. J Clin Microbiol. 1994;32:1542-6.
16. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA. 1996;275:452-7. DOI: 10.1001/jama.275.6.452